Trexquant Investment LP Takes $11.14 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Trexquant Investment LP purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,023 shares of the healthcare conglomerate's stock, valued at approximately $11,141,000.

Other institutional investors have also recently bought and sold shares of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $25,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $32,000. Pillar Financial Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $40,000. Finally, DecisionPoint Financial LLC increased its position in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after acquiring an additional 62 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research report on Friday, December 6th. Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Stephens boosted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a research report on Thursday, December 5th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of "Buy" and a consensus price target of $629.32.

Remove Ads

UnitedHealth Group Stock Performance

UNH stock traded up $17.67 during trading hours on Thursday, hitting $540.87. 6,454,806 shares of the stock were exchanged, compared to its average volume of 4,243,146. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a 50-day simple moving average of $509.39 and a two-hundred day simple moving average of $542.82. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The firm has a market capitalization of $494.74 billion, a P/E ratio of 34.89, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the firm posted $5.83 EPS. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.33% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.